This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
News & Press: Journals

JTH Editors Highlight Three Clinical Studies in Preview of March Issue

Friday, February 24, 2017   (0 Comments)
Share |

Journal of Thrombosis and Haemostasis (JTH) Editors Pieter Rietsma and Frits Rosendaal are highlighting three clinical studies that will be included in the March issue. Read their message below:

"There are three newsworthy clinical studies in the March issue of JTH. The first describes a successful clinical trial with a prolonged half-life factor VIII in patients with hemophilia A. The second study examines bleeding risk in terminally ill patients, and identifies cancer, recent bleeding, thromboprofylaxis and antiplatelet therapy as independent risk factors. The interaction between amiodarone, a class III antiarrythmic drug, and warfarin is the subject of the third study. This study concludes that close INR monitoring is required when initiating amiodarone in patients who are taking vitamin K antagonist."


Membership Management Software Powered by YourMembership  ::  Legal